Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | CAD | P27708 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1178957 | 1.00 | ALOX15 (0.48) | ALOX15ALDH1A1CADLMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL21247032 | 0.98 | ALOX15 (0.46) | ALOX15ALDH1A1CADLMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL21247031 | 0.98 | ALOX15 (0.46) | ALOX15ALDH1A1CADLMNAHSD17B10 | |
| SCHEMBL14016339 | 0.83 | ALOX15 (0.48) | ALOX15ALDH1A1CADLMNAHSD17B10 | |
| SCHEMBL31589297 | 0.83 | HCAR2 (0.35) | ALOX15ALDH1A1LMNAHSD17B10KMT2A | |
| SCHEMBL1172849 | 0.82 | MGAM (0.48) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| SCHEMBL2617390 | 0.82 | MGAM (0.48) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| SCHEMBL20028702 | 0.82 | ALDH1A1 (0.44) | ALOX15ALDH1A1CADLMNAHSD17B10 | |
| SCHEMBL1074665 | 0.82 | ALOX15 (0.42) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| SCHEMBL1172846 | 0.82 | MGAM (0.48) | ALOX15ALDH1A1LMNAHSD17B10MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| CN-120040435-A | Mangiferin and derivatives thereof, preparation method and medical application thereof | 安徽中医药大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | disclosed |
| WO-2019104851-A4 | BETA-HYDROXYBUTYRYL-AMINO ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 刘成 | 2019-08-15 | — | — | WO | disclosed |
| CN-109153670-A | Nicotinyl alcohol ether derivative, preparation method thereof, pharmaceutical composition and application | 中国医学科学院药物研究所 | 2019-01-04 | — | — | CN | disclosed |
| US-20110263539-A1 | SHIP 1 MODULATOR COMPOUNDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-10-27 | — | — | US | disclosed |
| US-20100323990-A1 | SHIP 1 MODULATOR PRODRUGS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2010-12-23 | — | — | US | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0948506-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| EP-0948502-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| US-5945082-A | HERBICIDES, INSECTICIDES, FLAME RETARDANTS, PLASTICIZERS; CYANATION, SALT FORMATION, PHOSPHONATION, PHOSPHATING | MONSANTO COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| US-5935542-A | Cyanphosphonate derivatives and method for their preparation | MONSANTO COMPANY (US) | 1999-08-10 | — | — | US | disclosed |
| WO-1998029422-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998029419-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100323990-A1 | SHIP 1 MODULATOR PRODRUGS | PPM1D, PPM1G, PPM1F | ALOX15 1115/4885ALDH1A1 598/4885CAD 3593/4885 |
| US-20110263539-A1 | SHIP 1 MODULATOR COMPOUNDS | PPM1F, PPM1D, PPP1R1B | ALOX15 1048/4885ALDH1A1 980/4885CAD 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.